503b semaglutide FDA Moves to Exclude Semaglutide, Tizerpatide, and Liraglutide from Bulk Substances List Is 503B the New 340B?:

Semaglutide injections might be a suitable option for patients who are currently struggling with obesity and have been unsuccessful in using other weight loss methods

If poor handling causes 30% potency loss, that $150 vial is only delivering $105 worth of active peptide

While described as nonselective at other melanocortin receptors, its clinical effects are predominantly MC1R-mediated

Something to consider when choosing your water volume, especially with expensive compounds

This compound may be reconstituted using an appropriate sterile solvent in a controlled laboratory environment

Shortage worries: Past supply issues left many people scrambling